Press Releases

June 9, 2021
–   JMP Securities Life Sciences Conference –   Raymond James Human Health Innovation Conference BOTHELL, Wash., June 09, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc.  (NASDAQ: ATHA) (“ Athira “), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore
June 1, 2021
BOTHELL, Wash., June 01, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc.  (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the appointment of Mark Worthington as the company’s
May 26, 2021
- Jefferies Healthcare Conference - Goldman Sachs 42 nd Annual Global Healthcare Conference BOTHELL, Wash., May 26, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc.  (NASDAQ: ATHA) (“ Athira ”), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal
March 24, 2021
BOTHELL, Wash., March 24, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that Leen Kawas, Ph.D., President and Chief Executive
Displaying 1 - 10 of 17
Print Page
Email Alerts
Contact IR